Alan Dunton

Track

Insider profile

Currently holds positions in Oragenics Inc, Palatin Technologies Inc and CorMedix Inc

Performance

Overall performance
4.1
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 29% 8.2% 15.1%
Success rate 97% 68% 82%
Transactions
9 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 261%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Independent Director Oragenics Inc April 1, 2011 -
Independent Director Palatin Technologies Inc June 22, 2011 -
Independent Director CorMedix Inc March 1, 2019 -
Non-Executive Director Bionomics Ltd Sept. 29, 2015 - July 4, 2016
Independent Director Gyre Therapeutics Inc Oct. 18, 2006 - Dec. 11, 2014
Non-Executive Chairman of the Board Immune Pharmaceuticals Inc Jan. 2, 2012 - Aug. 25, 2013
Alan Dunton's trades of CorMedix Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US CorMedix Inc (CRMD)
Transaction date
Sale
Price
46.68
Quantity 18,995 +9.5%
Value US$1,219,572
US CorMedix Inc (CRMD)
Transaction date
Proposed sale
Price
221.92
Quantity 77,437
Value US$4,077,029
US CorMedix Inc (CRMD)
Transaction date
Sale
Price
330.98
Quantity 89,297 -22.7%
Value US$2,532,173
US CorMedix Inc (CRMD)
Transaction date
Proposed sale
Price
13.10
Quantity 10,000
Value US$130,950
US Oragenics Inc (OGEN)
Transaction date
Sale
Price
0.36
Quantity 66 -0.3%
Value US$24
US Oragenics Inc (OGEN)
Transaction date
Proposed sale
Price
0.34
Quantity 66
Value US$22
US CorMedix Inc (CRMD)
Transaction date
Purchase
Price
3.30
Quantity 3,000 +24.5%
Value US$9,900
US CorMedix Inc (CRMD)
Transaction date
Purchase
Price
3.45
Quantity 3,000 +32.4%
Value US$10,350
Transaction date
Sale
Price
2.48
Quantity 199 -0.4%
Value US$494
Transaction date
Proposed sale
Price
2.05
Quantity 200
Value US$410
Transaction date
Sale
Price
2.97
Quantity 200 -0.5%
Value US$594
US CorMedix Inc (CRMD)
Transaction date
Purchase
Price
3.95
Quantity 5,000 +400.0%
Value US$19,750
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-02 2025-12-30
US CorMedix Inc (CRMD)
S Sale
18,995 +9.5%
46.68
US$1,219,572 		18,995 +9.5% 46.68 US$1,219,572
2025-12-30 2025-12-30
US CorMedix Inc (CRMD)
PrS Proposed sale
77,437
221.92
US$4,077,029 		77,437 221.92 US$4,077,029
2025-09-16 2025-09-12
US CorMedix Inc (CRMD)
S Sale
89,297 -22.7%
330.98
US$2,532,173 		89,297 -22.7% 330.98 US$2,532,173
2025-09-12 2025-09-12
US CorMedix Inc (CRMD)
PrS Proposed sale
10,000
13.10
US$130,950 		10,000 13.10 US$130,950
2025-06-17 2025-06-13
B Purchase
200 +0.1%
20,000.00
US$4,000,000 		200 +0.1% 20,000.00 US$4,000,000
2024-12-09 2024-12-06
US Oragenics Inc (OGEN)
S Sale
66 -0.3%
0.36
US$24 		66 -0.3% 0.36 US$24
2024-12-06 2024-12-06
US Oragenics Inc (OGEN)
PrS Proposed sale
66
0.34
US$22 		66 0.34 US$22
2023-12-18 2023-12-15
US CorMedix Inc (CRMD)
B Purchase
3,000 +24.5%
3.30
US$9,900 		3,000 +24.5% 3.30 US$9,900
2023-12-18 2023-12-14
US CorMedix Inc (CRMD)
B Purchase
3,000 +32.4%
3.45
US$10,350 		3,000 +32.4% 3.45 US$10,350
2023-12-06 2023-12-06
PrS Proposed sale
160
2.51
US$402 		160 2.51 US$402
2023-12-06 2023-12-04
S Sale
1 -0.0%
2.46
US$2 		1 -0.0% 2.46 US$2
2023-12-06 2023-12-04
S Sale
199 -0.4%
2.48
US$494 		199 -0.4% 2.48 US$494
2023-12-01 2023-12-01
PrS Proposed sale
200
2.05
US$410 		200 2.05 US$410
2022-12-23 2022-12-21
S Sale
200 -0.5%
2.97
US$594 		200 -0.5% 2.97 US$594
2020-08-14 2020-08-12
US CorMedix Inc (CRMD)
B Purchase
5,000 +400.0%
3.95
US$19,750 		5,000 +400.0% 3.95 US$19,750